Recombinant growth hormone (GH) treatments have been the norm for treating childhood short stature resulting from factors such as GH deficiency. Globally, concerns have been raised about the association between childhood GH treatments and long-term mortality due to cancer incidence in adulthood.
Further information: cordis.europa.eu